(NEW YORK)Canadian drug developer Biovail Corp. said Thursday its profit fell more than 35 percent in the third quarter on lower sales of its blockbuster antidepressant Wellbutrin and higher...READ MORE

(NEW YORK)Canadian drug developer Biovail Corp. said Thursday it is being sued by investors who allege it made misleading statements during the approval process for the depression drug Aplen...READ MORE

(TORONTO)Canadian drugmaker Biovail Corp. has bought privately held U.S. drug company Prestwick Pharmaceuticals Inc. for $100 million, company officials said Wednesday.READ MORE

(NEW YORK)Canadian drugmaker Biovail Corp. said Wednesday it is seeking U.S. approval to market a generic version of a blockbuster cholesterol drug from Abbott Laboratories.READ MORE

(NEW YORK)Drugmaker Biovail said Monday that Canadian health regulators have expanded use of its pain medication Ralivia. The Canadian pharmaceutical firm said the once-a-day pill is now app...READ MORE

(NEW YORK)Canadian drug developer Biovail Corp. said Thursday it named Peggy Mulligan chief financial officer, effective Sept. 3. She replaces Adrian A. De Saldanha, who had been serving as ...READ MORE

Among the earnings stories for Wednesday, Aug. 13, from AP Financial News: AMSTERDAM, Netherlands (AP)--ING Groep NV, the Dutch insurer and bank, said Wednesday its second quarter ...READ MORE